Results 111 to 120 of about 26,503 (228)

Randomly Methylated β-Cyclodextrin Inclusion Complex with Ketoconazole: Preparation, Characterization, and Improvement of Pharmacological Profiles

Molecules
As a powerful imidazole antifungal drug, ketoconazole’s low solubility (0.017 mg/mL), together with its odor and irritation, limited its clinical applications.
Yili Ding, Shufeng Xu, Charles Ding, Zhiyuan Zhang, Zhe Xu   +4 more
doaj   +1 more source

The Global Antifungal Susceptibility Epidemiology of Trichophyton indotineae Indicating Voriconazole as an Alternative Therapy for Recalcitrant Dermatophytosis

Mycoses, Volume 69, Issue 6, June 2026.
ABSTRACT Background The emergence of Trichophyton indotineae as a multidrug‐resistant dermatophyte has challenged conventional therapeutic approaches for dermatophytosis, leading to a significant therapeutic dilemma. The absence of formal epidemiological cutoff values (ECVs) under the Clinical and Laboratory Standards Institute (CLSI) framework has led
Ge Song, Wenting Xie, Xiaodong She, Weida Liu, Xiaofang Li, Guanzhao Liang   +5 more
wiley   +1 more source

Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs

Veterinary Dermatology, Volume 37, Issue 3, Page 419-426, June 2026.
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain, Andrew Lowe, Elizabeth A. Mauldin   +2 more
wiley   +1 more source

Mechanism of cytochrome P450-3A inhibition by ketoconazole

, 2011
Objectives Ketoconazole is extensively used as an index inhibitor of cytochrome P450-3A (CYP3A) activity in vitro and in vivo, but the mechanism of ketoconazole inhibition of CYP3A still is not clearly established.
Sarah J Parent, Michael H Court, David J Greenblatt, Su X Duan, Yanli Zhao, Lisa L von Moltke, Jerold S Harmatz, Karthik Venkatakrishnan   +7 more
core   +1 more source

Paediatric Acute Generalised and Localised Exanthematous Pustulosis: A Systematic Review

JEADV Clinical Practice, Volume 5, Issue 2, Page 678-681, June 2026.
Miranda K. Branyiczky, Megan Lowe, Eric McMullen, Shireen Dumont, Narachai Julanon, Vincent Piguet, Cathryn Sibbald   +6 more
wiley   +1 more source

Determination of Ketoconazole in Tablets by Using Three Different Methods

, 2012
Ketoconazole has been widely used as an antifungal drug that is formulated as tablets, cream and overthecounter ketoconazole shampoo. The aim of this research was to study and to standardize an ultraviolet spectrophotometric (UVS) method ...
Gjorgjeska, Biljana, Biljana Gjorgjeska
core   +1 more source

Ketoconazole: a reappraisal. [PDF]

BMJ, 1985
openaire   +2 more sources

Giant Pityriasis Versicolor

JEADV Clinical Practice, Volume 5, Issue 2, Page 708-709, June 2026.
Sunil Jaiswal, Shraddha Uprety, Pratichya Thapa, Aditi Joshi, Prakriti Lamichhane   +4 more
wiley   +1 more source

Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. [PDF]

, 1994
Bogner, Johannes R., Eva Thoma‐Greber, H. C. Korting, Goebel, Frank-Detlef, Korting, H. C., Thoma-Greber, E., F.‐D. Goebel, J. Bogner   +7 more
core   +1 more source

FERMENZA®: a patented natural alternative to ketoconazole and zinc pyrithione for managing dandruff and scalp disorders

Frontiers in Industrial Microbiology
BackgroundDandruff and related scalp disorders, often caused by Malassezia furfur, pose significant dermatological challenges. This study evaluates FERMENZA®, a novel, patented formulation derived from pomegranate and beetroot fermented extracts, as a ...
Sudip Ghosh, Munna Bhattacharya
doaj   +1 more source